Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Oct;127(4):e146-e148.
doi: 10.1016/j.bja.2021.07.005. Epub 2021 Jul 20.

Vasopressin infusion in COVID-19 critical illness is not associated with impaired viral clearance: a pilot study

Affiliations
Comment

Vasopressin infusion in COVID-19 critical illness is not associated with impaired viral clearance: a pilot study

Daniel E Leisman et al. Br J Anaesth. 2021 Oct.
No abstract available

Keywords: COVID-19; SARS-CoV-2; angiotensin-converting enzyme 2; arginine vasopressin; vasopressor; viraemia.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Viral mRNA levels over time in vasopressin treated vs. non-treated patients. Blue circles represent individual vasopressin-treated patients and purple circles represent individual non-treated patients. Dashed lines connect measurements within the same patient. Squares show the group mean at the indicated time point and error bars indicate the 95% confidence intervals. β indicates the regression coefficient for vasopressin treatment association with viral mRNA level at the indicated time point, adjusted for the Day 0 level.

Comment on

References

    1. Alhazzani W., Møller M.H., Arabi Y.M., et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) Crit Care Med. 2020;48:e440–e469. - PMC - PubMed
    1. Guérin C., Reignier J., Richard J.C., et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368:2159–2168. - PubMed
    1. Russell J.A., Walley K.R., Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877–887. - PubMed
    1. Currigan D.A., Hughes R.J., Wright C.E., Angus J.A., Soeding P.F. Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries: an in vitro study. Anesthesiology. 2014;121:930–936. - PubMed
    1. Sarkar J., Golden P.J., Kajiura L.N., Murata L.A., Uyehara C.F. Vasopressin decreases pulmonary-to-systemic vascular resistance ratio in a porcine model of severe hemorrhagic shock. Shock. 2015;43:475–482. - PubMed